Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russ A Kuker

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2008
Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolismMichalis F Georgiou, Ati Gonenc, Drenna Waldrop-Valverde, et al.
JCO Clinical Cancer Informatics|July 16, 2025
Deep Learning-Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 TrialRuss A Kuker, Juan P Alderuccio, Sunwoo Han, et al.
Cancers|November 11, 2022
A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-Cell LymphomaRuss A Kuker, David Lehmkuhl, Deukwoo Kwon, et al.
Thyroid : Official Journal of the American Thyroid Association|February 10, 2016
(124)I PET/CT in Patients with Differentiated Thyroid Cancer: Clinical and Quantitative Image AnalysisSeza A Gulec, Russ A Kuker, Mohammed Goryawala, et al.
Leukemia & Lymphoma|August 20, 2021
Prognostic value of presalvage metabolic tumor volume in patients with relapsed/refractory diffuse large B-cell lymphomaJuan Pablo Alderuccio, Russ A Kuker, Priscila Barreto-Coelho, et al.
American Journal of Hematology|May 21, 2025
PET/CT in the Staging and Treatment Response Assessment of Patients With Extranodal Marginal Zone LymphomaJuan Pablo Alderuccio, Russ A Kuker, Eduardo Edelman Saul, et al.
The Lancet. Haematology|December 11, 2024
Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trialJuan Pablo Alderuccio, Alvaro J Alencar, Jonathan H Schatz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2023
PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical TrialJuan Pablo Alderuccio, Isildinha M Reis, Mehdi Hamadani, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2008
Analysis of the effects of injecting drug use and HIV-1 infection on 18F-FDG PET brain metabolismMichalis F Georgiou, Ati Gonenc, Drenna Waldrop-Valverde, et al.
JCO Clinical Cancer Informatics|July 16, 2025
Deep Learning-Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 TrialRuss A Kuker, Juan P Alderuccio, Sunwoo Han, et al.
Cancers|November 11, 2022
A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-Cell LymphomaRuss A Kuker, David Lehmkuhl, Deukwoo Kwon, et al.
Thyroid : Official Journal of the American Thyroid Association|February 10, 2016
(124)I PET/CT in Patients with Differentiated Thyroid Cancer: Clinical and Quantitative Image AnalysisSeza A Gulec, Russ A Kuker, Mohammed Goryawala, et al.
Leukemia & Lymphoma|August 20, 2021
Prognostic value of presalvage metabolic tumor volume in patients with relapsed/refractory diffuse large B-cell lymphomaJuan Pablo Alderuccio, Russ A Kuker, Priscila Barreto-Coelho, et al.
American Journal of Hematology|May 21, 2025
PET/CT in the Staging and Treatment Response Assessment of Patients With Extranodal Marginal Zone LymphomaJuan Pablo Alderuccio, Russ A Kuker, Eduardo Edelman Saul, et al.
The Lancet. Haematology|December 11, 2024
Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trialJuan Pablo Alderuccio, Alvaro J Alencar, Jonathan H Schatz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2023
PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical TrialJuan Pablo Alderuccio, Isildinha M Reis, Mehdi Hamadani, et al.
Pageof 2